CD4 and pneumocystosis: Two patients developed PCP infections before routine monitoring of CD4+ counts, none of the monitored patients (who received PCP prophylaxis with cotrimoxazol in case CD4+ counts decreased below 0.2*109/l) developed a PCP infection.